Breast and ovarian cancer is estimated to be responsible for 20% of cancer mortality among women 1 . Familial breast cancer can result from impaired control of genome stability after mutations in proteins that carry out repair through homologous recombination, such as BRCA2 (refs. 2,3). In mammalian cells, homologous recombination has emerged as the main mechanism for the error-free homologydirected repair of DNA double-strand breaks (DSBs) during the S and G2 phases of the cell cycle. The central activity of homologous recombination is performed by the RAD51 protein, which catalyzes the invasion of resected ends of the DSB into the intact sister chromatids 4 . BRCA2 is pivotal in controlling the function and localization of RAD51. The BRC repeats located at the center of BRCA2 are involved in a complicated mode of regulation. These repeats bind RAD51 and control RAD51 nucleoprotein filament formation in conjunction with the BRCA2 DNA-binding domain, whereas another RAD51-binding motif at the C terminus of BRCA2, unrelated to the BRC repeats, seems to stabilize the filament [5] [6] [7] [8] . Point mutations in BRC repeats are found in individuals predisposed to breast cancer (http://research. nhgri.nih.gov/bic/).
Breast and ovarian cancer is estimated to be responsible for 20% of cancer mortality among women 1 . Familial breast cancer can result from impaired control of genome stability after mutations in proteins that carry out repair through homologous recombination, such as BRCA2 (refs. 2,3) . In mammalian cells, homologous recombination has emerged as the main mechanism for the error-free homologydirected repair of DNA double-strand breaks (DSBs) during the S and G2 phases of the cell cycle. The central activity of homologous recombination is performed by the RAD51 protein, which catalyzes the invasion of resected ends of the DSB into the intact sister chromatids 4 . BRCA2 is pivotal in controlling the function and localization of RAD51. The BRC repeats located at the center of BRCA2 are involved in a complicated mode of regulation. These repeats bind RAD51 and control RAD51 nucleoprotein filament formation in conjunction with the BRCA2 DNA-binding domain, whereas another RAD51-binding motif at the C terminus of BRCA2, unrelated to the BRC repeats, seems to stabilize the filament [5] [6] [7] [8] . Point mutations in BRC repeats are found in individuals predisposed to breast cancer (http://research. nhgri.nih.gov/bic/).
Homologous recombination can be divided into three steps: the presynaptic stage involves RAD51 nucleoprotein filament assembly, the synaptic stage is characterized by strand invasion and branch migration, and the postsynaptic stage includes Holliday-junction formation and resolution. Once a DSB is created, the nuclease activities of MRE11, CtIP and EXO1 (refs. 9-11) are required for processing the DSB to generate the replication protein A (RPA)-coated single-stranded DNA (ssDNA) that is needed for recruitment of ATM and Rad3-related (ATR) kinase and subsequent phosphorylation and activation of CHK1 (ref. 12) . RPA has high affinity for 3′ ssDNA tails, leading to inhibition of RAD51 loading and homologous recombination. Recombination mediators, such as the BRCA2 homolog Brh2, overcome the inhibitory effect of RPA and allow RAD51 to nucleate on the ssDNA to promote presynaptic filament assembly 13 .
PALB2 has been identified as a partner of BRCA2 and shown to be an essential upstream regulator of BRCA2′s intranuclear localization and its homologous recombination function 14 . Furthermore, multiple independent studies have established PALB2 as the central core of a BRCA1-PALB2-BRCA2 complex essential for homologous recombination [15] [16] [17] . About a dozen PALB2-truncating mutations have been found, in several countries, that are associated with a two-to six-fold increased risk of breast cancer 18, 19 . Like BRCA2 (also known as FANCD1), PALB2 (FANCN) is mutated in a subgroup of Fanconi anemia 20, 21 . Recently, PALB2 has also been linked to pancreatic cancer susceptibility, being the second most frequently mutated gene in affected people, after BRCA2 (ref. 22) . Thus, like BRCA2, PALB2 is at the crossroads of breast cancer, pancreatic cancer and Fanconi anemia. Like other Fanconi anemia cells, PALB2 mutant cells show increased chromosome breakage after treatment with drugs causing interstrand cross-links, consistent with PALB2 having a role in DNA repair. But although PALB2 affects homologous recombination and genome stability, biochemical insights into PALB2 are lacking. 
r t i c l e s
Here we have purified the PALB2 tumor suppressor, and we show that PALB2 is a DNA-binding protein that physically interacts with RAD51. Analysis of the DNA-binding properties of PALB2 revealed a preference for the D-loop structure. PALB2 strongly stimulates the DNA strand-invasion activity of RAD51 and stabilizes the nucleoprotein filament against a disruptive BRC3-BRC4 polypeptide. Moreover, PALB2 can work in concert with a BRCA2 construct to further promote D-loop formation. Consistent with PALB2 having a role in homologous recombination, PALB2-deficient cells, like BRCA2-deficient cells, are sensitive to a PARP inhibitor. Our findings establish PALB2 as an important regulator of homologous recombination.
RESULTS

Purified PALB2 binds DNA
Short interfering RNA knockdown of PALB2 leads to a decrease in homologous recombination 14 and also to mitomycin C-induced formation of RAD51 foci ( Supplementary Fig. 1a-c) . To better understand the role of PALB2 in homologous recombination, we purified the PALB2 protein from insect cells (Fig. 1a) . As PALB2 is a chromatin-bound protein 14 , we tested whether PALB2 could bind DNA directly. DNA mobility shift assays revealed that PALB2 bound ssDNA, double-stranded DNA (dsDNA), splayed arms, Holliday junctions and D-loop structures with different affinities ( Supplementary  Fig. 2a-g ). Competition assays were carried out to establish the preferred substrate. PALB2 bound D loop preferentially over ssDNA, splayed arms, Holliday junctions and dsDNA (Fig. 1b) . At 0.5 nM PALB2, 40% of D loop was bound, followed by ssDNA and splayed arms (15-30%), compared with 1-15% for all other DNA substrates (Fig. 1c) . PALB2-DNA complexes resolved on an agarose gel were supershifted with a PALB2 antibody, suggesting that the DNA-binding activity is PALB2 dependent (Fig. 1d) . PALB2's preferential binding to D-loop structures was not affected by competition with an excess of ssDNA of different lengths (60 nucleotides (nt), 91 nt or 4,300 nt), suggesting that the D loop is the most preferred substrate. Binding to dsDNA was vastly reduced in the presence of ssDNA (60 and 91 nt), whereas addition of dsDNA (4,300 base pairs (bp)) had little effect on ssDNA binding (Supplementary Fig. 2h) .
We further explored PALB2-DNA association using EM with linear tailed DNA that comprised both single-stranded and double-stranded regions. First, we observed that isolated PALB2 particles formed ringor open-ring-like structures (Fig. 1e, inset micrographs) . PALB2 was then found to be completely concentrated at the ends of the tailed DNA, whereas the remaining DNA was protein-free. These results show that PALB2 associates preferentially with the substrate's ssDNA portion, over the dsDNA portion.
PALB2 enhances DNA recombination and interacts with RAD51
PALB2's specific binding of D-loop structures led us to propose that PALB2 is involved in the invasion step of homologous recombination. Therefore, we tested whether PALB2 has biochemical activities related to homologous recombination. First, we examined whether PALB2 could enhance strand exchange in vitro using a linear ssDNA oligonucleotide and a homologous linear duplex DNA 23 (Fig. 2a) . Indeed, addition of PALB2 to RAD51, at a saturating concentration of RAD51, further increased strand exchange (compare lanes 5 and 6 with lane 2), as measured by the release of ssDNA. In contrast, PALB2 alone did not promote strand exchange efficiently (lanes 3 and 4). Second, we found that PALB2 also acted on another crucial step of homologous recombination by promoting the conjoining of DNA molecules through the capture of dsDNA by PALB2-ssDNA complexes (Fig. 2b) . Moreover, PALB2-dependent DNA capture increased synergistically with RAD51 concentration.
As PALB2 showed these activities in the absence of BRCA2, we tested whether PALB2 enhances homologous recombination by interacting with RAD51 directly. A series of non-overlapping glutathione S-transferase (GST) fusion proteins (designated P2T1 to P2T5, for 'PALB2 truncations 1-5' , and R51T1 to R51T4, for 'RAD51 truncations 1-4'; Fig. 3a) were used to define the regions of PALB2 that interact with RAD51 and vice versa. GST pull-down assays revealed that RAD51 interacted with the N terminus (amino acid residues 1-200) of PALB2 and also its C terminus (residues 853-1186) (Fig. 3b) . In the opposite experiment, immunoprecipitation analyses revealed that purified PALB2 bound RAD51 at residues 184-257 (Fig. 3c) . Collectively, these results show that residues 184-257 of RAD51 interact with PALB2 at its C and N termini (Fig. 3d) . In addition, coimmunoprecipitation of purified RAD51 and PALB2 proteins was observed (Fig. 3e) .
Having established the domains responsible for the interaction, we asked which region(s) of PALB2 could bind DNA. D loop Of DNA molecules observed, 86% had both ends bound, whereas 14% had one end bound. Drawing represents the DNA and PALB2-DNA complexes. a r t i c l e s was very efficiently bound by the N-terminal coiled-coil domain of PALB2 (residues 1-200, found in P2T1) and by a region of unknown function encompassing residues 372-561 (P2T3) (Fig. 4a,b and Supplementary Fig. 3 ). Unlike the full-length protein or P2T1, P2T3 did not bind Holliday junctions, suggesting that P2T1 has more affinity for these structures.
A key step in homologous recombination is the formation of a D-loop structure, characterized by the invasion of an ssDNA substrate into a homologous duplex DNA. We tested whether PALB2 enhances RAD51-mediated strand invasion using an ssDNA oligonucleotide. In this experiment, RAD51 was included at saturating concentration (300 nM), and practically no D-loop products were observed (Fig. 4c, lane 3) . Although PALB2 did not promote strand invasion by itself (lane 2), adding increasing amounts of PALB2 to the RAD51 reaction led to a ten-fold increase in D-loop product formation (lane 8). The stimulation of RAD51 activity by PALB2 was dependent on the presence of ATP and supercoiled DNA (lanes 9 and 10, respectively).
To further demonstrate that PALB2 stimulates strand invasion by RAD51, we used a D-loop assay with substrates more similar to those found in eukaryotes in vivo 24 . In this assay, a linear duplex substrate (4.3 kilobases (kb)) with an exposed 3′ tail (approximately 200 nt) is created by treatment of linear duplex DNA with exonuclease T7. The proteins of interest are incubated with this substrate, and homologous supercoiled DNA is added. The use of such a large substrate eliminates possible artifacts caused by oligonucleotides annealing to transitory single-stranded regions in the supercoiled DNA during strand invasion assays. Similar to reactions with oligonucleotides, PALB2 stimulated RAD51 D-loop formation (~20-fold activation compared to RAD51 alone; Fig. 4d , compare lanes 3 and 8). PALB2 also showed annealing activity in the absence of supercoiled DNA (Fig. 4d, asterisk ). These results demonstrate that PALB2 can strongly enhance RAD51 function in D-loop assays.
PALB2 and piBRCA2 stimulate D-loop formation
As BRCA2 is a binding partner of PALB2 (ref. 14), we investigated whether BRCA2 could work synergistically with PALB2. Because purification of BRCA2 poses technical challenges owing to its large size (3,418 amino acid residues), we purified a BRCA2 construct (termed piccolo, Italian for 'small' , or piBRCA2) containing the PALB2-binding domain, BRC3 and BRC4 repeats, the three OB folds and the TR2 RAD51-binding region (Fig. 5a) .
We used several approaches to test whether piBRCA2 is functional in vivo and in vitro. First, we investigated whether piBRCA2 localized to a unique DNA DSB in vivo (Fig. 5b) . After cleavage with the endonuclease I-SceI and DSB formation in DR95 cells 25 , piBRCA2 colocalized with the DSB marker γ-H2AX 26-28 as well as with endogenous PALB2. Notably, cells that were not transfected with I-SceI did not show colocalization of piBRCA2 with γ-H2AX or PALB2 at the DSB (data not shown). Second, we found that piBRCA2 interacted with endogenous RAD51 and PALB2 (Fig. 5c) . Deletion of PALB2's WD40 domain, which is important for BRCA2 binding to PALB2 (ref. 14) , stopped the interaction between piBRCA2 and PALB2 ( Fig. 5d) . Third, consistent with BRCA2 controlling the nuclear localization of RAD51 (ref. 5), expression of piBRCA2 in BRCA2-knockdown cells restored the nuclear accumulation of RAD51, as judged with cell-fractionation assays (Fig. 5e) , and the formation of RAD51 foci (Supplementary Fig. 4) . The RAD51 foci appeared smaller and more diffuse than in normal cells, suggesting that additional portions of BRCA2 might help to sustain RAD51 foci formation. In contrast, piBRCA2 did not restore nuclear abundance of RAD51 in PALB2 knockdown cells (Supplementary Fig. 4c) . Fourth, like the Brh2 protein of Ustilago maydis 13 Figure 2 PALB2 stimulates RAD51 strand exchange and DNA capture. (a) PALB2 stimulates RAD51-mediated strand exchange. RAD51 or PALB2, or both, were mixed with 1.5 μM 63-mer ssDNA. DNA strand exchange was initiated by addition of 3 μM homologous 63-bp dsDNA in which the strand that would be displaced during DNA strand exchange was 32 P labeled (shown as an asterisk). (b) Left, scheme of the second capture strategy (Supplementary Methods). Right, second capture assays with PALB2, RAD51 or both. PALB2 and RAD51 were incubated with beads containing 1 μM of 5′-biotinylated ssDNA poly(dT). Then 300 nM of nonhomologous dsDNA was added to the DNA-protein complex. Proteins bound to the beads were eluted with SDS and analyzed by polyacrylamide gel electrophoresis. a r t i c l e s the inhibitory effect of RPA and acted as a recombination mediator (Fig. 5f) . Fifth, piBRCA2 promoted dsDNA capture ( Supplementary  Fig. 5a ). Together, these results show that piBRCA2 has the key functions of full-length BRCA2.
Having established that piBRCA2 is functional in vitro and in vivo, we tested whether piBRCA2 could bind DNA and promote D-loop formation. Purified piBRCA2 bound D loops and ssDNA efficiently (Fig. 6a,b) but did not promote D-loop formation on its own (Fig. 6c, lane 2 ; 70 nM). Rather, it promoted the annealing of 3′-tailed DNA molecules (lane 2, asterisk). However, piBRCA2 stimulated RAD51-mediated homologous pairing by more than 20-fold (lane 8) in an ATP-dependent manner (lane 9). Similar results were obtained with ssDNA oligonucleotides (Supplementary Fig. 5b ). Next, we examined whether PALB2 and piBRCA2 could function together in D-loop assays. Adding piBRCA2 (15 or 20 nM) and PALB2 (30 or 40 nM) to a RAD51 reaction led to a highly synergistic stimulation of RAD51 (25-fold activation; Fig. 6d) .
We then investigated the biochemical mechanisms by which PALB2 stimulates homologous recombination. Although RPA is essential for recombination, it also inhibits RAD51 filament complexes. The beads were washed and treated with SDS to elute the bound proteins, then western blotted with antibodies to RAD51. (c) GST alone or GST-tagged RAD51 fragments were incubated with or without PALB2, followed by immunoprecipitation (IP) using PALB2 antibodies and western blotting against PALB2 and GST. ,186 aa  200  561  853  372   P2 T1  P2 T2  P2 T3  P2 T4  P2 T5   RAD51 WT   1  337 aa  101  257  184   R51 T1  R51 T2  R51 T3  R51 GST alone or GST-tagged PALB2 fragments purified from bacteria were incubated with RAD51, and glutathione Sepharose beads were used to capture protein a r t i c l e s formation. Therefore, homologous recombination requires accessory factors, termed mediators, to overcome the inhibitory effect of RPA and allow RAD51 binding on ssDNA 29 . We tested whether PALB2 could perform such a function. The addition of 100 nM RPA completely prevented the association of RAD51 with ssDNAlinked beads (Fig. 7a, lane 2) . When PALB2 was added in increasing concentrations after RAD51 and RPA, RAD51 gained access to the ssDNA, as evidenced by the increasing amounts of RAD51 bound to ssDNA beads (lanes 3-7). Under these conditions, RPA70 was still bound to DNA, suggesting a ternary complex containing RAD51, PALB2 and RPA on ssDNAs. These results show that PALB2 helps RAD51 to overcome the suppressive effect of RPA and functions as a recombination mediator. It has previously been shown that BRC3 and BRC4 at high concentrations can disrupt RAD51 filament formation by blocking nucleation on DNA 5 . In vivo, the expression of BRC3 reduces homologous recombination and RAD51 foci formation, consistent with an inhibitory role 30 . Hence, we purified a GST fusion protein bearing BRCA2's BRC3 and BRC4 repeats (BRC3/4-GST; Fig. 7b, left gel) . In the absence of the BRC3/4-GST protein, RAD51 bound to the ssDNA, forming distinct protein-ssDNA complexes (Fig. 7b, right  gel, lane 2) . However, the addition of BRC3/4-GST led to a reduction of DNA binding (lanes 3-6). Next, we performed D-loop reactions in the presence of the disruptive BRC3/4-GST protein to find out whether the addition of PALB2 would overcome this effect. Control reactions showed that RAD51-mediated D-loop formation in the presence of RPA (Fig. 7c, lane 5) was inhibited when BRC3/4-GST was added to the reaction. In contrast, adding purified PALB2 before the addition of BRC3/4-GST had a protective effect (lanes 9-12). This demonstrates that PALB2 can stabilize the RAD51 filament in the presence of disrupting BRC3/4-GST (Fig. 7c,d) .
BRCA2-deficient cells have been found to be highly sensitive to potent poly(ADP-ribose) polymerase (PARP) inhibitors 31, 32 . Inhibition of PARP leads to the persistence of ssDNA lesions, which collapse DNA replication forks, yielding DSBs that are normally repaired by homologous recombination; cells lacking BRCA1 or BRCA2 have a severe deficit in homologous recombination that greatly sensitizes them to these effects. Given that PALB2 and BRCA2 are both mediators of homologous recombination, we tested whether PARP inhibitors could also efficiently kill PALB2-deficient cells. Indeed, PARP inhibitor (AZD2281) was cytotoxic for PALB2-deficient cells (EUFA1341) as compared with the control cell line FEN5280 (Fig. 7e) . This indicates that tumors harboring PALB2 mutations are likely to be sensitive to PARP inhibition.
DISCUSSION
Cellular DNA is constantly exposed to endogenous and exogenous DNA damage, which, if unrepaired or misrepaired, will compromise genome integrity and promote tumorigenesis. These deleterious effects of DNA damage are limited by the action of certain tumor-suppressor proteins, such as BRCA1, BRCA2 and PALB2. It is generally believed that these proteins exert their tumor-suppression function, at least in part, by promoting homologous recombination-based, faithful DSB repair. In this study, we have investigated the biochemical functions of the Whole-cell extracts were prepared and immunoprecipitations (IP) were conducted using IgG alone, anti-Flag or anti-PALB2, followed by western blotting with the indicated antibodies. (e) Nuclear localization of RAD51 is restored in the presence of piBRCA2. HeLa cells were transfected with a short interfering RNA against BRCA2 (siBRCA2), and with a plasmid expressing piBRCA2-Flag or with no plasmid. Cell fractions were analyzed by western blotting for piBRCA2 and endogenous BRCA2 and RAD51. Immunoblots against GAPDH and histone H3 were positive controls for cytosolic and chromatin fractions, respectively. WT, wild type . (f) piBRCA2 overcomes RPA inhibition to promote RAD51 assembly. RPA bound to an ssDNA oligonucleotide prevents RAD51 assembly (lane 2), whereas addition of piBRCA2 stimulates RAD51 filament formation in the presence of RPA (lanes 3-7) . The stimulation was weaker in the absence of ATP and Mg 2+ (lane 8). Lanes 9-11, interaction of RPA, RAD51 and PALB2 on beads alone. a r t i c l e s PALB2 protein in homologous recombination. During this process, the RAD51 recombinase polymerizes as a right-handed helical filament on ssDNA and forms the presynaptic filament. This filament binds a recipient duplex DNA and searches for homology, leading to the formation of a joint molecule between the invading ssDNA and the recombining DNA, termed the D-loop structure. Using electrophoretic mobility shift assays (EMSAs), we have established that PALB2 is a DNA-binding protein with high affinity for D loop, which comprises single-stranded, double-stranded and branched DNA structures. The affinity for D-loop structures was very strong compared to that for ssDNA or dsDNA. A higher affinity for ssDNA compared to dsDNA was confirmed by EM visualization of PALB2 complexes on 3′-resected DNA ends. However, this higher affinity for ssDNA than dsDNA might result from DNA secondary structures or the sequences of the 33 , suggest that PALB2 has high affinity for dsDNA.
The DNA-binding properties of PALB2 are complex. Consistent with the identification of at least two DNA-binding sites (P2T1 and P2T3), the ratios of protein to oligonucleotide used in binding assays, and the observation that PALB2 homo-oligomerizes 34 , PALB2 seems to be able to bind multiple DNA molecules simultaneously. DNAcapture assays support this, as ssDNA and dsDNA were both efficiently captured from ssDNA-PALB2 beads (Supplementary Fig. 6 ). Both the P2T1 and P2T3 domains seem to be important for ssDNA binding, as fragments P2T1 and P2T3 bound the D-loop substrate relatively strongly but, in contrast to the full-length protein, showed reduced ssDNA binding. P2T3 did not bind Holliday junctions, suggesting that only P2T1 has the ability to bind these structures. The multiple DNA-binding sites of PALB2 might confer flexibility that allows the protein to distinguish damaged DNA in the context of collapsed replication forks, which could produce unusual DNA structures that need be recognized for DNA repair and genome stability.
PALB2 stimulates RAD51 for strand invasion and homologous recombination, as is also reported by Dray et al. in the accompanying paper 33 . The stimulatory effect depends on the presence of ATP and supercoiled DNA isolated in nondenaturing conditions. We were surprised to find that PALB2 could mediate this effect in the absence of BRCA2, and this prompted us to ask whether PALB2 can directly bind RAD51. Indeed, pull-down experiments showed that PALB2 interacts directly with RAD51 via two distinct segments in its N terminus (residues 1-200) and C terminus (residues 853-1186), whereas RAD51 binds to PALB2 through a region encompassing residues 184-257. Therefore, the enhancement of RAD51-mediated strand invasion by PALB2 might occur through interactions and stabilization of the RAD51 filament. A role for PALB2 in the regulation of RAD51 presynaptic filament through protein-protein interactions is consistent with the observation that PALB2 is required for RAD51 foci formation 21 . Although in vitro PALB2 can interact with RAD51 directly and stimulate RAD51-mediated strand invasion without BRCA2, in cells this stimulation probably occurs on DNA, after BRCA2 has enabled RAD51 loading on resected DNA.
The fact that PALB2 stabilized RAD51 nucleoprotein filament in the presence of BRC3/4 (Fig. 7c) is also notable. Given that PALB2 interacts directly with RAD51, this effect may be brought about by a direct protein-protein interaction, as PALB2 antibodies pulled down PALB2, BRC3/4 and RAD51 (Supplementary Fig. 7a) Previous studies have identified PALB2 as a BRCA2-interacting factor that binds to the extreme N terminus of BRCA2 (refs. 14,38). The PALB2-BRCA2 interaction is disrupted in breast and ovarian cancers by mutations in BRCA2 (refs. 14,38) . Given the close association of PALB2 and BRCA2 in the cell, we tested whether they could function together in strand invasion. Purification of BRCA2 is technically difficult, so we purified a BRCA2 chimera, piBRCA2, containing the PALB2-binding domain, BRC3 and BRC4 RAD51-binding sites, three OB folds for ssDNA binding and the TR2 RAD51-binding region. piBRCA2 had the known properties of BRCA2, as it localized to DNA damage sites, increased the accumulation of RAD51 in the nucleus and interacted with RAD51 and PALB2 in coimmunoprecipitation assays. Moreover, piBRCA2 also stimulated RAD51-mediated D-loop formation, similar to the BRCA2 homolog Brh2 from Ustilago maydis 39 or the Caenorhabditis elegans protein CeBRC-2 (ref. 40) . These results suggest that piBRCA2 represents a functional alternative to full-length BRCA2. When piBRCA2 and PALB2 were added together in the same reaction, they acted in concert to promote strand invasion, suggesting that they do not impede each other but rather work synergistically in stimulating RAD51 during the repair of DSBs (Fig. 8) .
Striking parallels can be drawn between BRCA2 and PALB2. Two regions of BRCA2, the BRC repeats and the TR2 region 6 , bind RAD51 and regulate RAD51-mediated homologous recombination 5 . Similarly, two regions of PALB2 bind RAD51, and PALB2 stimulates RAD51 for homologous recombination. Notably, both proteins bind RAD51 at the same site 41 , suggesting complex regulation. Both proteins can stimulate RAD51-mediated strand invasion. Thus, our data indicate that PALB2, at the functional level, might be more closely related to BRCA2 than previously anticipated. Hence, PALB2 function is not only important in targeting BRCA2 to chromatin but is also directly involved in the regulation of homologous recombination. However, as BRCA2-mutant cells (containing wild-type PALB2) are severely impaired in the accumulation of nuclear RAD51 and homologous recombination, it is unlikely that PALB2 can function adequately by itself in vivo, as a proportion of the RAD51 pool will not be nuclear. Therefore, in BRCA2-proficient cells, PALB2 probably acts together with BRCA2 to first overcome the inhibitory effect of RPA and recruit RAD51 to resected DSB ends, and then stimulate strand invasion into the undamaged sister chromatid. In BRCA2-deficient cells, PALB2 may help maintain a basal, albeit limited, homologous recombination function through its direct RAD51 binding and stimulating activity. This is consistent with the observation that the PALB2 A1025R mutant, which cannot bind BRCA2, had lower affinity for RAD51 than wild-type PALB2 (Supplementary Fig. 7b) . Such a basal level of homologous recombination, although not sufficient to suppress tumorigenesis, may be crucial for sustaining cell viability. One of the most successful outcomes of DNA repair studies at the clinical level is the use of PARP inhibitors on BRCA1-and BRCA2-deficient cells [42] [43] [44] . PALB2-deficient cells, as a result of their deficiency in homologous recombination, are also sensitive to PARP inhibitors, probably because collapsed replication forks resulting from the inhibition are not efficiently repaired. Together, our findings establish PALB2 as a crucial mediator of homologous recombination in human cells, thus providing a plausible mechanism for the development of cancer. Moreover, understanding of the function of PALB2 presented here may aid the design of a synthetic lethal therapeutic strategy for cancer treatment using PARP inhibitors.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/nsmb/. 
